Purchases and Sales Made in Q1 2025 in Eliem Therapeutics, Inc. (ELYM)
This table provides information about the institutional ownership of Eliem Therapeutics, Inc. (ELYM) during Q1 2025. The information is specifically focused on institutions that hold shares of Eliem Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2025
Q1 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-42.9K- 6.83% |
N/A
|
586K
$2.41M
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-49.9K- 21.98% |
N/A
|
177K
$727K
|
|
|
May 15, 2025
Q1 2025
|
Mariner, LLC
Overland Park, KS |
SELL
|
- |
-81.1K- 82.51% |
N/A
|
17.2K
$70.6K
|
|
|
May 15, 2025
Q1 2025
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-996K- 96.39% |
N/A
|
37.3K
$153K
|